Rhaeos
PrivateLast Round
Grant
Oct 9, 2023
Total Funding Raised
$15.84M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rhaeos operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Grant round in October 2023.
Rhaeos is a medical device company developing FlowSense, a noninvasive wearable sensor designed to monitor bodily fluid flow, initially for hydrocephalus patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhaeos Comparables
Compare Rhaeos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroDx Development | 91% | |
| Madison Scientific | 83% | |
| Kitea Health | 81% |
For institutional investors. Book with your work email.
Rhaeos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2023 | ||||
| Series A | Feb 16, 2023 | ||||
| Seed | Dec 23, 2021 | ||||
| Accelerator | Sep 27, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
Grant | Oct 6, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rhaeos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| NIH RADx | Grant, Accelerator |
| Creative Ventures | Series A, Seed |
| Lateral Capital | Series A, Seed |
| A1 Health Ventures | Grant |
| National Institute of Neurological Disorders and Stroke | Grant, Accelerator |
| Band of Angels | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 36% MoM, reaching 1.8K.
- Oct 9, 2023
$1.5M grant from A1 Health Ventures and NIH
For institutional investors. Book with your work email.
Rhaeos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rhaeos's valuation, stock price, and market status.
Is Rhaeos a public or private company?
Rhaeos is a private company.
What is the current stock price of Rhaeos?
Rhaeos is a private company, so its shares have no public market price. Caplight tracks Rhaeos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rhaeos worth (valuation)?
Valuation information for Rhaeos is not publicly available.
Can I buy Rhaeos stock?
Rhaeos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rhaeos's last funding round?
Rhaeos's most recent funding round was Grant on October 9, 2023.
Who are the main investors in Rhaeos?
Key investors in Rhaeos include Steele Foundation for Hope.
Will Rhaeos IPO soon?
No public IPO plans have been announced for Rhaeos.
How can I track Rhaeos secondary market activity?
Caplight tracks bids, offers, and trades in Rhaeos's shares on secondary markets.